Combination of Genetic and Quantitative Serological Immune Markers are Associated with Complicated Crohn’s Disease Behavior

BACKGROUND: Treatment of Crohn’s disease (CD) with biologics may alter disease progression, leading to fewer disease-related complications, but cost and adverse event profiles often limit their effective use. Tools identifying patients at high risk of complications, who would benefit the most from b...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lichtenstein, Gary R., Targan, Stephan R., Dubinsky, Marla C., Rotter, Jerome I., Barken, Derren M., Princen, Fred, Carroll, Susan, Brown, Michelle, Stachelski, Jordan, Chuang, Emil, Landers, Carol J., Stempak, Joanne M., Singh, Sharat, Silverberg, Mark S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4203682/
https://ncbi.nlm.nih.gov/pubmed/21391291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ibd.21661
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller